By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


CytomX Therapeutics, Inc. 

650 Gateway Boulevard
Suite 125
South San Francisco  California  94080-7014  U.S.A.
Phone: 650-515-4987 Fax: 650-351-0353



Company News
CytomX To Present At Oppenheimer's 26th Annual Healthcare Conference 12/1/2015 8:44:59 AM
CytomX Reports Third Quarter 2015 Financial Results 11/23/2015 8:17:30 AM
CytomX Highlights Data From Multiple Probody Pipeline Programs At Investor Event During AACR-National Cancer Institute-EORTC Conference 11/9/2015 7:05:50 AM
CytomX And MD Anderson Cancer Center Enter Into Strategic Collaboration For Probody-Enabled CAR-NK Cell Therapies 11/6/2015 6:11:36 AM
CytomX Appoints Matthew Young To Board Of Directors 11/3/2015 9:01:04 AM
Data From AACR's Probody Pipeline To Be Presented At The 2015 CytomX-NCI-EORTC International Conference On Molecular Targets And Cancer Therapeutics 10/27/2015 11:25:52 AM
CytomX Announces Closing Of Initial Public Offering And Full Exercise Of Underwriters' Option To Purchase Additional Shares 10/15/2015 8:45:31 AM
CytomX Announces Pricing Of Initial Public Offering 10/8/2015 6:27:50 AM
Analysts Closely Watch Bay Area CytomX's $80 Million IPO 10/8/2015 6:10:10 AM
Immuno-Oncology Veteran Rachel Humphrey, M.D., Joins CytomX As Chief Medical Officer 8/27/2015 6:22:06 AM